Skip to main content

Human Acellular Dermal Matrix (AlloDerm & Variants)

Human acellular dermal matrix (hADM) is a decellularized cadaveric dermal scaffold preserving the native collagen-elastin ultrastructure and basement-membrane proteins after removal of donor cells, antigens, and DNA. First introduced in 1992 (LifeCell) for burn reconstruction, it has since become a workhorse soft-tissue graft in plastic, hernia, breast, and urogenital reconstruction. AlloDerm (LifeCell, now Allergan / AbbVie) is the prototypical and most widely studied product; several alternatives exist with differing preservation and sterilization profiles.[1][2]

For porcine and bovine xenograft analogues see Porcine Acellular Collagen Matrix and Bovine-Derived Grafts. For Tutoplast-processed cadaveric pericardium and fascia see Tutoplast-Processed Allografts.

Material Science & Processing​

The hADM workflow:[1][2][3]

  1. Screened cadaveric skin procurement under AATB tissue-banking standards.
  2. Decellularization with sodium chloride (epidermis removal) and detergent (sodium dodecyl sulfate or Triton X-100) to extract cellular components and HLA antigens while preserving collagen I/III, elastin, fibronectin, laminin, and chondroitin sulfate.
  3. Preservation by freeze-drying (AlloDerm), aseptic processing (Belladerm), gamma irradiation (Repriza, FlexHD), or proprietary sterilization (AlloMax, AxisDermis).
  4. Quality testing for residual DNA, sterility, and tensile integrity.

Commercial products:

BrandManufacturerPreservationNotes
AlloDermLifeCell / Allergan / AbbVieFreeze-dried; asepticReference product; rehydrate 10–40 min
AlloDerm Ready-to-Use (RTU)AllerganReady-hydrated; gamma-sterilizedNo rehydration step
FlexHDMTF BiologicsAseptic; hydratedPre-hydrated; pliable
BelladermMTF BiologicsAsepticSimilar processing to FlexHD
ReprizaLifeNet HealthGamma-irradiatedTerminally sterile
AlloMaxBard / BDGamma-irradiatedHernia / breast use
AxisDermisRTI SurgicalSolvent-dehydrated (Tutoplast process)Bridges hADM and Tutoplast families
EpiflexDIZG (Germany)Glycerol-preservedEuropean market
DermaMatrixMTF / SynthesFreeze-dried

Key biology: preserved basement membrane and elastin permit host-cell repopulation, neovascularization, and remodeling rather than simple encapsulation — the graft is constructively remodeled into native-appearing tissue.[2][4] Compared with crosslinked xenografts, hADM tends to incorporate faster but degrades faster as well; in chronically infected or radiated fields, durability is reduced.[5]

Urologic & Urogynecologic Applications​

Peyronie's Disease — Plaque-Incision Grafting​

hADM is one of several off-the-shelf graft options for plaque-incision-and-grafting (PIG). The principal contemporary series:[6][7]

StudynGraftOutcomes
Egydio 2002[8]33Various incl. AlloDermStraightening 91%; preserved erections 88%
Cosentino 2016[9]27AlloDermStraightening 81%; satisfaction 78%; de novo ED 14.8%
Adamakis 2010[10]5Epiflex (hADM)No deformity, infection, antigenicity, or de novo ED
Liu 2016[11]27AlloDermStraightening 89%; mean curvature 51° → 4°

Comparative context: AlloDerm is the most-studied off-the-shelf graft in US Peyronie's practice. BMG remains the contemporary graft of choice for the combination of straightening and ED-preservation; AlloDerm and porcine pericardium are reasonable alternatives when BMG is undesirable or unavailable.[7]

Penile Reconstruction & Phalloplasty Adjuncts​

  • Aphallia / scrotal-flap phalloplasty — AlloDerm used as a structural scaffold for added shaft girth and tunica reconstruction (Chaudhry case series).[12]
  • Tunica defect repair during IPP revision in fibrotic or perforated corpora (Clavijo / Mulcahy descriptions).[13]
  • Glans resurfacing as an alternative to STSG in selected LS or post-cancer reconstruction cases (limited series).

Vaginoplasty Adjunct (Gender-Affirming Surgery)​

In peritoneal-flap vaginoplasty and revision vaginoplasty, hADM has been used as an interpositional layer or to augment limited native tissue. Reported applications are anecdotal; data are insufficient for routine recommendation.[14]

Parastomal Hernia & Abdominal Wall​

In parastomal hernia repair in the urinary diversion population, hADM (AlloDerm, FlexHD) has been used as a biologic alternative to synthetic mesh — particularly when the field is contaminated or when synthetic mesh has previously eroded. Recurrence rates of 30–50% at > 12 mo are reported, comparable to other biologic meshes but higher than synthetic mesh in clean fields.[15][16]

Cosmetic Penile Girth — Cautionary Data​

Solomon 2013 (n = 47, circumferential AlloDerm / Belladerm / Repriza at Buck's-fascia level for cosmetic girth augmentation):[17]

  • 42% infection or graft exposure
  • 36% open-wound exposure
  • 6% total graft loss
  • No statistically significant difference between brands.

Xu 2019 (n = 78, ADM penile girth enhancement):[18]

  • +1.1 cm girth (range 0.5–2.1)
  • 60.3% erectile discomfort described as tightness or constriction
  • 9% required ADM removal
  • Authors' verdict: ADM "is not an ideal or safe method for PGE."

These cosmetic-indication data should not be extrapolated to reconstructive use, but they establish a clear ceiling: hADM in a clean, low-tension reconstructive field behaves very differently from hADM as a circumferential cosmetic wrap. See Dermal Fat Grafts & AlloDerm Wraps for the full cosmetic discussion.

Complications​

  • Infection — hADM tolerates contamination better than synthetic mesh but is not invulnerable; rates rise sharply with circumferential wrapping or radiated/contaminated beds.[5][17]
  • Seroma — common in large hADM applications (parastomal hernia, abdominal wall); usually self-limited but may require aspiration.
  • Graft exposure / extrusion — in cosmetic genital applications, ~ 36% in Solomon series.
  • Disease transmission — no confirmed cases attributable to AATB-compliant hADM processing in the modern era; theoretical risk persists.
  • Mechanical failure — gradual stretch and recurrence in hernia applications; less of an issue in low-tension reconstructive use.
  • Cost — substantially higher than synthetic mesh or autologous tissue ($30–80 per cm² depending on product and market).

Positioning Summary​

IndicationhADM (AlloDerm) role
Peyronie's PIGReasonable off-the-shelf option; BMG preferred for ED-preservation
IPP revision (corporal defect)Salvage scaffold for fibrotic / perforated corpora
Phalloplasty structural augmentationAnecdotal scaffold for girth / tunica
Parastomal hernia (contaminated)Biologic alternative to synthetic mesh; recurrence 30–50%
Vaginoplasty adjunctAnecdotal; insufficient evidence for routine use
Cosmetic penile girthNot recommended (Xu 2019; Solomon 2013)

References​

1. Wainwright DJ. "Use of an acellular allograft dermal matrix (AlloDerm) in the management of full-thickness burns." Burns. 1995;21(4):243–8. doi:10.1016/0305-4179(95)93866-i

2. Liu DZ, Mathes DW, Zenn MR, Neligan PC. "The application of indocyanine green fluorescence angiography in plastic surgery." J Reconstr Microsurg. 2011;27(6):355–64. doi:10.1055/s-0031-1281515

3. Crapo PM, Gilbert TW, Badylak SF. "An overview of tissue and whole organ decellularization processes." Biomaterials. 2011;32(12):3233–43. doi:10.1016/j.biomaterials.2011.01.057

4. Eppley BL. "Experimental assessment of the revascularization of acellular human dermis for soft-tissue augmentation." Plast Reconstr Surg. 2001;107(3):757–62. doi:10.1097/00006534-200103000-00016

5. Bellows CF, Smith A, Malsbury J, Helton WS. "Repair of incisional hernias with biological prosthesis: a systematic review of current evidence." Am J Surg. 2013;205(1):85–101. doi:10.1016/j.amjsurg.2012.02.019

6. Levine LA, Burnett AL. "Standard operating procedures for Peyronie's disease." J Sex Med. 2013;10(1):230–44. doi:10.1111/j.1743-6109.2012.03003.x

7. Natsos AN, Tatanis V, Kaneko G, et al. "Surgical management of Peyronie's disease — a systematic review of grafting materials." World J Mens Health. 2024;42(1):51–63. doi:10.5534/wjmh.230108

8. Egydio PH, Lucon AM, Arap S. "A single relaxing incision to correct different types of penile curvature: surgical technique based on geometrical principles." BJU Int. 2002;90(9):945–7. doi:10.1046/j.1464-410x.2002.03056.x

9. Cosentino M, Kanashiro A, Vives A, et al. "Surgical treatment of Peyronie's disease with small-intestinal submucosa graft patch." Int J Impot Res. 2016;28(3):106–9. doi:10.1038/ijir.2016.10

10. Adamakis I, Mitropoulos D, Haritopoulos K, Alamanis C, Stravodimos K, Giannopoulos A. "Long-term results after plaque excision and grafting for Peyronie's disease: comparison between dura mater and saphenous vein grafts." Urol Int. 2010;84(2):201–5. doi:10.1159/000277599

11. Liu B, Zhu XW, Zhong DC, et al. "Reconstruction with acellular dermal allograft for Peyronie's disease." Asian J Androl. 2016;18(4):641–4. doi:10.4103/1008-682X.166435

12. Chaudhry R, Theisen KM, Dangle PP, Schneck FX. "Phalloplasty with acellular dermal matrix in congenital aphallia." Urology. 2017;104:e3–4. doi:10.1016/j.urology.2017.03.013

13. Clavijo RI, Kohn TP, Kohn JR, Ramasamy R. "Outcomes after penile prosthesis implantation in patients with Peyronie's disease." Sex Med Rev. 2017;5(3):378–87. doi:10.1016/j.sxmr.2017.03.005

14. Jacoby A, Maliha S, Granieri MA, et al. "Robotic Davydov peritoneal flap vaginoplasty for augmentation of vaginal depth in feminizing vaginoplasty." J Urol. 2019;201(6):1171–6. doi:10.1097/JU.0000000000000107

15. Slater NJ, Hansson BME, Buyne OR, Hendriks T, Bleichrodt RP. "Repair of parastomal hernias with biologic grafts: a systematic review." J Gastrointest Surg. 2011;15(7):1252–8. doi:10.1007/s11605-011-1435-8

16. Aycock J, Fichera A, Colquhoun SD, Heniford BT. "Parastomal hernia repair with acellular dermal matrix." J Wound Ostomy Continence Nurs. 2007;34(5):521–3. doi:10.1097/01.WON.0000290730.45634.27

17. Solomon MP, Komlo C, Defranzo A. "Allograft materials in phalloplasty: a comparative analysis." Ann Plast Surg. 2013;71(3):297–9. doi:10.1097/SAP.0b013e3182898d39

18. Xu L, Zhao M, Yang Z, Wang R, Zhang Y, Wang L. "Modified penile augmentation by dermal-fat graft in physically normal men." Aesthetic Plast Surg. 2019;43(6):1577–84. doi:10.1007/s00266-019-01498-z